person · Reporting owner
Nolan Mangini Siobhan
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alight, Inc. / DelawareALIT · Entity 5436 | Director | July 02, 2026 | July 07, 2026 |
| CASTLIGHT HEALTH, INC.CSLT · Entity 130187 | President | February 16, 2020 | February 19, 2020 |
| NGM BIOPHARMACEUTICALS INCNGM · Entity 11997 | President and CFO | March 02, 2023 | March 06, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alight, Inc. / Delaware
Report date July 02, 2026 · Filed July 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 17,153 |
Reported balance
After 2026-07-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-02 · Grant · Acquired 14,025 · Balance 17,153 F1: Represents restricted stock units granted for annual board service, pursuant to the Issuer's 2021 Omnibus Share Plan, which are scheduled to vest on July 2, 2027. F2: Includes restricted stock units scheduled to vest in the future. F3: Securities listed in this filing have been adjusted to reflect a 1-for-20 reverse split of the Issuer's Class A common stock effective as of June 30, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted for annual board service, pursuant to the Issuer's 2021 Omnibus Share Plan, which are scheduled to vest on July 2, 2027.
F2: Includes restricted stock units scheduled to vest in the future.
F3: Securities listed in this filing have been adjusted to reflect a 1-for-20 reverse split of the Issuer's Class A common stock effective as of June 30, 2026.
CASTLIGHT HEALTH, INC.
Report date February 16, 2020 · Filed February 19, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table I · non-derivative | Direct | 438,998 |
Ending reported balance
After 2020-02-18 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2020-02-16 · Exercise / conversion · Acquired 1,875 · Balance 391,765 Row 2 · 2020-02-16 · Exercise / conversion · Acquired 15,625 · Balance 407,390 Row 3 · 2020-02-16 · Exercise / conversion · Acquired 6,250 · Balance 413,640 Row 4 · 2020-02-16 · Exercise / conversion · Acquired 11,250 · Balance 424,890 Row 5 · 2020-02-16 · Exercise / conversion · Acquired 23,063 · Balance 447,953 Row 6 · 2020-02-16 · Exercise / conversion · Acquired 25,862 · Balance 473,815 Row 7 · 2020-02-18 · Sale · Disposed 34,817 · Balance 438,998 F1: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.21 to $1.26 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-02-16 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-02-16 · Exercise / conversion · Disposed 1,875 · Balance 0 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F4: 1/4th of the RSUs vested on February 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 31,250 |
Reported balance
After 2020-02-16 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2020-02-16 · Exercise / conversion · Disposed 15,625 · Balance 31,250 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: 1/4th of the RSUs vested on August 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 25,000 |
Reported balance
After 2020-02-16 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2020-02-16 · Exercise / conversion · Disposed 6,250 · Balance 25,000 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F6: 1/4th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 90,010 |
Reported balance
After 2020-02-16 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2020-02-16 · Exercise / conversion · Disposed 11,250 · Balance 90,010 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F7: 1/16th of the RSUs vested on May 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 276,750 |
Reported balance
After 2020-02-16 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2020-02-16 · Exercise / conversion · Disposed 23,063 · Balance 276,750 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F8: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 362,069 |
Reported balance
After 2020-02-16 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2020-02-16 · Exercise / conversion · Disposed 25,862 · Balance 362,069 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F9: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.21 to $1.26 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration.
F4: 1/4th of the RSUs vested on February 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F5: 1/4th of the RSUs vested on August 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F6: 1/4th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F7: 1/16th of the RSUs vested on May 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F8: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F9: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
NGM BIOPHARMACEUTICALS INC
Report date March 02, 2023 · Filed March 06, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 76,000 |
Reported balance
After 2023-03-02 transaction · row 1
1 source rowRow 1 · 2023-03-02 · Grant · Acquired 76,000 · Balance 76,000 F1: Represents shares of common stock issuable upon the vesting and settlement of restricted stock units ("RSUs"). 1/4th of the RSUs vest on each of January 15, 2024, January 15, 2025, January 15, 2026 and January 15, 2027. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.36 · Expires 2033-03-01 | Direct | 228,000 |
Reported balance
After 2023-03-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-03-02 · Grant · Acquired 228,000 · Balance 228,000 F2: The shares subject to the stock option vest over a four-year period commencing January 1, 2023, with 1/48th of the shares vesting on a monthly basis. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.36 · Expires 2033-03-01 | Direct | 200,000 |
Reported balance
After 2023-03-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-02 · Grant · Acquired 200,000 · Balance 200,000 F3: 1/2 of the shares subject to the stock option vest on the first anniversary of the grant date of March 2, 2023 (the "2023 Grant Date"), and the remaining 1/2 of the shares vest on the second anniversary of the 2023 Grant Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock issuable upon the vesting and settlement of restricted stock units ("RSUs"). 1/4th of the RSUs vest on each of January 15, 2024, January 15, 2025, January 15, 2026 and January 15, 2027.
F2: The shares subject to the stock option vest over a four-year period commencing January 1, 2023, with 1/48th of the shares vesting on a monthly basis.
F3: 1/2 of the shares subject to the stock option vest on the first anniversary of the grant date of March 2, 2023 (the "2023 Grant Date"), and the remaining 1/2 of the shares vest on the second anniversary of the 2023 Grant Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 02, 2026 Filed Jul 7, 2026 21:56 UTC | Alight, Inc. / Delaware ALIT · Entity 5436 | GrantClass A Common Stock | 14,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-047564 · wk-form4_1783461388.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,153 F1 · shares: Represents restricted stock units granted for annual board service, pursuant to the Issuer's 2021 Omnibus Share Plan, which are scheduled to vest on July 2, 2027. F2 · balance_after: Includes restricted stock units scheduled to vest in the future. F3 · balance_after: Securities listed in this filing have been adjusted to reflect a 1-for-20 reverse split of the Issuer's Class A common stock effective as of June 30, 2026. Read SEC document |
| July 02, 2025 Filed Jul 7, 2025 21:12 UTC | Alight, Inc. / Delaware ALIT · Entity 5436 | GrantClass A Common Stock | 33,783 | $0.00 | $0.00 |
DisclosureSEC source: 0001809104-25-000213 · wk-form4_1751922767.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,572 F1 · shares: Represents restricted stock units granted for annual board service, pursuant to the Issuer's 2021 Omnibus Share Plan, which are scheduled to vest on July 2, 2026. F2 · balance_after: Includes RSUs scheduled to vest in the future. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 22:56 UTC | Alight, Inc. / Delaware ALIT · Entity 5436 | GrantClass A Common Stock | 10,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001809104-25-000022 · wk-form4_1737154589.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,789 F1 · shares: Represents a pro rata equity award of Restricted Stock Units ("RSUs") granted for board service from January 2, 2025 through July 2, 2025, the annual grant date. The RSUs are scheduled to vest on January 2, 2026. F2 · balance_after: Includes RSUs scheduled to vest in the future. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 22:25 UTC | Alight, Inc. / Delaware ALIT · Entity 5436 | GrantClass A Common Stock | 17,835 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001164 · ownership.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,835 F1 · shares: Represents restricted stock units ("RSUs") granted, pursuant to the Issuer's 2021 Omnibus Incentive Plan, for annual board service in connection with the Reporting Person's appointment to the Issuer's Board of Directors. The RSUs are schedule to vest on January 2, 2025. F2 · balance_after: Includes RSUs scheduled to vest in the future. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 17:12 UTC | NGM BIOPHARMACEUTICALS INC NGM · Entity 11997 | GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $4.36 | $0.00 |
DisclosureSEC source: 0001209191-23-016401 · doc4.xml · derivative · entry 3 Nolan Mangini Siobhan · CIK 0001679464 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2033-03-01 F3 · derivative.exercise_date: 1/2 of the shares subject to the stock option vest on the first anniversary of the grant date of March 2, 2023 (the "2023 Grant Date"), and the remaining 1/2 of the shares vest on the second anniversary of the 2023 Grant Date. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 17:12 UTC | NGM BIOPHARMACEUTICALS INC NGM · Entity 11997 | GrantStock Option (Right to Buy) · Derivative | 228,000 | $0.00 Strike: $4.36 | $0.00 |
DisclosureSEC source: 0001209191-23-016401 · doc4.xml · derivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,000 Underlying: Common Stock · 228,000 shares Expires 2033-03-01 F2 · derivative.exercise_date: The shares subject to the stock option vest over a four-year period commencing January 1, 2023, with 1/48th of the shares vesting on a monthly basis. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 17:12 UTC | NGM BIOPHARMACEUTICALS INC NGM · Entity 11997 | GrantCommon Stock | 76,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016401 · doc4.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,000 F1 · shares: Represents shares of common stock issuable upon the vesting and settlement of restricted stock units ("RSUs"). 1/4th of the RSUs vest on each of January 15, 2024, January 15, 2025, January 15, 2026 and January 15, 2027. Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 18:36 UTC | NGM BIOPHARMACEUTICALS INC NGM · Entity 11997 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $12.78 | $0.00 |
DisclosureSEC source: 0001209191-22-040348 · doc4.xml · derivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-06-30 F1 · derivative.exercise_date: The shares subject to the stock option vest over a four-year period measured from from July 1, 2022, with 1/48th of the shares vesting on a monthly basis, subject to the reporting person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan) as of each such vesting date. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 16:05 UTC | NGM BIOPHARMACEUTICALS INC NGM · Entity 11997 | GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $15.20 | $0.00 |
DisclosureSEC source: 0001209191-22-016186 · doc4.xml · derivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-03-02 F1 · derivative.exercise_date: The shares subject to the stock option vest over a four-year period commencing January 1, 2022, with 1/48th of the shares vesting on a monthly basis. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 20:26 UTC | NGM BIOPHARMACEUTICALS INC NGM · Entity 11997 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $31.93 | $0.00 |
DisclosureSEC source: 0001209191-21-021933 · doc4.xml · derivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-03-16 F1 · derivative.exercise_date: The shares subject to the stock option vest over a four-year period commencing January 1, 2021, with 1/48th of the shares vesting on a monthly basis. Read SEC document |
| August 03, 2020 Filed Feb 3, 2021 16:47 UTC | NGM BIOPHARMACEUTICALS INC NGM · Entity 11997 | GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $18.88 | $0.00 |
DisclosureSEC source: 0001209191-21-007292 · doc4.xml · derivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2030-08-02 F1 · derivative.exercise_date: The shares subject to the stock option vest over a four-year period, with 1/4th vesting on July 13, 2021 and the remainder vesting in 36 equal monthly installments thereafter. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 21:09 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 34,817 | $1.23 | $42,723.94 |
DisclosureSEC source: 0001209191-20-010858 · doc4.xml · nonDerivative · entry 7 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438,998 F1 · kind: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.21 to $1.26 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:09 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 25,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010858 · doc4.xml · derivative · entry 13 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,069 Underlying: Class B Common Stock · 25,862 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F9 · derivative.exercise_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F9 · derivative.expiration_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:09 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 23,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010858 · doc4.xml · derivative · entry 12 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,750 Underlying: Class B Common Stock · 23,063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F8 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F8 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:09 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010858 · doc4.xml · derivative · entry 11 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,010 Underlying: Class B Common Stock · 11,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F7 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F7 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:09 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010858 · doc4.xml · derivative · entry 10 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class B Common Stock · 6,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F6 · derivative.exercise_date: 1/4th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F6 · derivative.expiration_date: 1/4th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:09 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010858 · doc4.xml · derivative · entry 9 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Class B Common Stock · 15,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5 · derivative.exercise_date: 1/4th of the RSUs vested on August 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F5 · derivative.expiration_date: 1/4th of the RSUs vested on August 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:09 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010858 · doc4.xml · derivative · entry 8 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: 1/4th of the RSUs vested on February 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F4 · derivative.expiration_date: 1/4th of the RSUs vested on February 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:09 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 25,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010858 · doc4.xml · nonDerivative · entry 6 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,815 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:09 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 23,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010858 · doc4.xml · nonDerivative · entry 5 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:09 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010858 · doc4.xml · nonDerivative · entry 4 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:09 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010858 · doc4.xml · nonDerivative · entry 3 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:09 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010858 · doc4.xml · nonDerivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:09 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010858 · doc4.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 18:58 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 16,234 | $1.27 | $20,594.45 |
DisclosureSEC source: 0001567619-20-000434 · doc1.xml · nonDerivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,890 F1 · shares: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.25 to $1.28 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 18:58 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 33,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-000434 · doc1.xml · derivative · entry 3 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,300 Underlying: Class B Common Stock · 33,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: 33.3% of the RSUs will vest on December 31, 2018, 33.3% of the RSUs will vest on December 31, 2019 and the remaining 33.3% of the RSUs will vest on December 31, 2020. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F4 · derivative.expiration_date: 33.3% of the RSUs will vest on December 31, 2018, 33.3% of the RSUs will vest on December 31, 2019 and the remaining 33.3% of the RSUs will vest on December 31, 2020. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 18:58 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 33,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-000434 · doc1.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 20:12 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 31,656 | $1.34 | $42,561.49 |
DisclosureSEC source: 0001567619-19-021908 · doc1.xml · nonDerivative · entry 8 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,824 F1 · kind: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.275 to $1.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:12 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantPerformance Stock Unit (PSU) · Derivative | 103,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021908 · doc1.xml · derivative · entry 16 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,449 Underlying: Class B Common Stock · 103,449 shares Expires 2021-08-16 F11 · derivative.exercise_price: Each PSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. The PSU vests on August 17, 2020, subject to the continuing service of the Reporting Person on such date. F10 · shares: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F11 · derivative.exercise_date: Each PSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. The PSU vests on August 17, 2020, subject to the continuing service of the Reporting Person on such date. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:12 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 25,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021908 · doc1.xml · derivative · entry 15 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,931 Underlying: Class B Common Stock · 25,862 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F10 · derivative.exercise_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F10 · derivative.expiration_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:12 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 23,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021908 · doc1.xml · derivative · entry 14 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,813 Underlying: Class B Common Stock · 23,062 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F9 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F9 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:12 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021908 · doc1.xml · derivative · entry 13 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,260 Underlying: Class B Common Stock · 11,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F8 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2018, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F8 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2018, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:12 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021908 · doc1.xml · derivative · entry 12 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Class B Common Stock · 6,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F7 · derivative.exercise_date: 1/4th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F7 · derivative.expiration_date: 1/4th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:12 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021908 · doc1.xml · derivative · entry 11 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,875 Underlying: Class B Common Stock · 15,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F6 · derivative.exercise_date: 1/4th of the RSUs vested on August 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F6 · derivative.expiration_date: 1/4th of the RSUs vested on August 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:12 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021908 · doc1.xml · derivative · entry 10 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 Underlying: Class B Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5 · derivative.exercise_date: 1/4th of the RSUs vested on February 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F5 · derivative.expiration_date: 1/4th of the RSUs vested on February 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:12 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021908 · doc1.xml · derivative · entry 9 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: 1/4th of the RSUs vested on November 16, 2016, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F4 · derivative.expiration_date: 1/4th of the RSUs vested on November 16, 2016, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:12 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 25,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021908 · doc1.xml · nonDerivative · entry 7 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:12 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 23,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021908 · doc1.xml · nonDerivative · entry 6 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:12 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021908 · doc1.xml · nonDerivative · entry 5 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:12 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021908 · doc1.xml · nonDerivative · entry 4 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:12 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021908 · doc1.xml · nonDerivative · entry 3 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:12 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021908 · doc1.xml · nonDerivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:12 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021908 · doc1.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 19:14 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 21,617 | $1.41 | $30,387.02 |
DisclosureSEC source: 0001567619-19-017370 · doc1.xml · nonDerivative · entry 7 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,056 F1 · shares: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.375 to $1.435 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 16, 2019 Filed Aug 16, 2019 18:37 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 652 | $1.38 | $899.76 |
DisclosureSEC source: 0001567619-19-017209 · doc1.xml · nonDerivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,110 F2 · shares: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.38 to $1.39 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:14 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantRestricted Stock Units (Class B Common Stock) · Derivative | 413,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017370 · doc1.xml · derivative · entry 14 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,793 Underlying: Common Stock · 413,793 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F10 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over four years, beginning on November 16,2019. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F10 · derivative.expiration_date: The RSUs will vest in equal quarterly installments over four years, beginning on November 16,2019. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:14 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 23,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017370 · doc1.xml · derivative · entry 13 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,875 Underlying: Class B Common Stock · 23,063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F9 · derivative.exercise_date: The RSUs vested in equal quarterly installments over four years, beginning on May 16,2019. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F9 · derivative.expiration_date: The RSUs vested in equal quarterly installments over four years, beginning on May 16,2019. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:14 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017370 · doc1.xml · derivative · entry 12 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Underlying: Class B Common Stock · 11,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F8 · derivative.exercise_date: The RSUs vested in equal quarterly installments over four years, beginning on May 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F8 · derivative.expiration_date: The RSUs vested in equal quarterly installments over four years, beginning on May 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:14 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017370 · doc1.xml · derivative · entry 11 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Class B Common Stock · 6,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F7 · derivative.exercise_date: 25% of the RSUs vested on February 16, 2018 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F7 · derivative.expiration_date: 25% of the RSUs vested on February 16, 2018 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:14 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017370 · doc1.xml · derivative · entry 10 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Class B Common Stock · 15,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F6 · derivative.exercise_date: 25% of the RSUs vested on August 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F6 · derivative.expiration_date: 25% of the RSUs vested on August 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.